Clinical Trial Update: Apatinib Combined with Temozolomide and Etoposide Capsules in the Treatment of Recurrent Medulloblastoma in Children [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating apatinib in combination with temozolomide and etoposide capsules for recurrent medulloblastoma in children; currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Medulloblastoma

Drugs mentioned

• Apatinib (apatinib)
• Etoposide (Etoposide)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Beijing Sanbo Brain Hospital | Conditions: Recurrent Medulloblastoma | Phase 2 | Status: RECRUITING